NHIRD and TriNetX in Rheumatology: Opportunities and Challenges
- PMID: 40207535
- DOI: 10.1111/1756-185X.70203
NHIRD and TriNetX in Rheumatology: Opportunities and Challenges
References
-
- S. B. Yong, J. Y. Huang, J. Y. Chiou, and J. C. C. Wei, “Adult Outcome of Juvenile Idiopathic Arthritis: A Nationwide Population‐Based Retrospective Cohort Study in Taiwan,” International Journal of Rheumatic Diseases 22, no. 7 (2019): 1283–1288.
-
- J. B. Bilsborrow, D. I. Peláez‐Ballestas, B. Pons‐Estel, et al., “Global Rheumatology Research: Frontiers, Challenges, and Opportunities,” Arthritis and Rheumatology 74, no. 1 (2022): 1–4, https://doi.org/10.1002/art.41980.
-
- R. W. Sanson‐Fisher, B. Bonevski, L. W. Green, and C. D'Este, “Limitations of the Randomized Controlled Trial in Evaluating Population‐Based Health Interventions,” American Journal of Preventive Medicine 33, no. 2 (2007): 155–161.
-
- S. V. Wang, S. Pinheiro, W. Hua, et al., “STaRT‐RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies,” BMJ 372 (2021): m4856, https://doi.org/10.1136/bmj.m4856.
-
- C. Y. Hsieh, C. C. Su, S. C. Shao, et al., “Taiwan's National Health Insurance Research Database: Past and Future,” Clinical Epidemiology 11 (2019): 349–358.
Publication types
LinkOut - more resources
Full Text Sources
